These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35358697)
41. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952 [TBL] [Abstract][Full Text] [Related]
42. Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery Platform. Metcalf CA; Svenson S; Hwang J; Tripathi S; Gangal G; Kabir S; Lazarus D; Cole R; Sweryda-Krawiec B; Shum P; Brown D; Case RI; van der Poll D; Rohde E; Harlfinger S; Teng CH; Eliasof S J Med Chem; 2019 Nov; 62(21):9541-9559. PubMed ID: 31593466 [TBL] [Abstract][Full Text] [Related]
43. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
44. Docetaxel prodrug self-assembled nanosystem: Synthesis, formulation and cytotoxicity. Jing F; Guo Q; Xu W; Qu H; Sui Z Bioorg Med Chem Lett; 2018 Feb; 28(4):826-830. PubMed ID: 29395972 [TBL] [Abstract][Full Text] [Related]
45. In-vitro cytotoxicity and combination effects of the docetaxel-conjugated and doxorubicin-conjugated poly(lactic acid)-poly(ethylene glycol)-folate-based polymeric micelles in human ovarian cancer cells. Hami Z; Rezayat SM; Gilani K; Amini M; Ghazi-Khansari M J Pharm Pharmacol; 2017 Feb; 69(2):151-160. PubMed ID: 28044342 [TBL] [Abstract][Full Text] [Related]
46. Self-assembling poly(ethylene glycol)-block-polylactide-cabazitaxel conjugate nanoparticles for anticancer therapy with high efficacy and low in vivo toxicity. Shuai Q; Zhao G; Lian X; Wan J; Cen B; Zhang W; Liu J; Su W; Wang H Int J Pharm; 2020 Jan; 574():118879. PubMed ID: 31770581 [TBL] [Abstract][Full Text] [Related]
47. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645 [TBL] [Abstract][Full Text] [Related]
48. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955 [TBL] [Abstract][Full Text] [Related]
49. Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel. Kim DH; Termsarasab U; Cho HJ; Yoon IS; Lee JY; Moon HT; Kim DD Int J Nanomedicine; 2014; 9():5711-27. PubMed ID: 25525355 [TBL] [Abstract][Full Text] [Related]
50. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study. Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323 [TBL] [Abstract][Full Text] [Related]
51. A comparative study on the effect of docetaxel-albumin nanoparticles and docetaxel-loaded PEG-albumin nanoparticles against non-small cell lung cancer. Jin G; Jin M; Yin X; Jin Z; Chen L; Gao Z Int J Oncol; 2015 Nov; 47(5):1945-53. PubMed ID: 26398837 [TBL] [Abstract][Full Text] [Related]
53. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer. Jin G; Jin M; Jin Z; Gao Z; Yin X Oncol Rep; 2016 Aug; 36(2):871-6. PubMed ID: 27279008 [TBL] [Abstract][Full Text] [Related]
54. Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies. Koopaei MN; Dinarvand R; Amini M; Rabbani H; Emami S; Ostad SN; Atyabi F Int J Nanomedicine; 2011; 6():1903-12. PubMed ID: 21931485 [TBL] [Abstract][Full Text] [Related]
55. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells. Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023 [TBL] [Abstract][Full Text] [Related]
56. The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles. Wang JL; Du XJ; Yang JX; Shen S; Li HJ; Luo YL; Iqbal S; Xu CF; Ye XD; Cao J; Wang J Biomaterials; 2018 Nov; 182():104-113. PubMed ID: 30114562 [TBL] [Abstract][Full Text] [Related]
57. Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer. Grover A; Hirani A; Pathak Y; Sutariya V AAPS PharmSciTech; 2014 Dec; 15(6):1562-8. PubMed ID: 25134466 [TBL] [Abstract][Full Text] [Related]
58. Docetaxel-decorated anticancer drug and gold nanoparticles encapsulated apatite carrier for the treatment of liver cancer. Wan J; Ma X; Xu D; Yang B; Yang S; Han S J Photochem Photobiol B; 2018 Aug; 185():73-79. PubMed ID: 29870961 [TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]